Cathepsin F His Tag Protein: A Key Tool for Structural and Functional Research

1. Biological Characteristics of Cathepsin F

Cathepsin F is a key member of the lysosomal cysteine protease family, playing a crucial role in protein degradation and cellular metabolism. This protease exhibits typical cathepsin structural features, including a propeptide domain, catalytic domain, and C-terminal extension. Within cells, Cathepsin F primarily participates in physiological processes such as antigen presentation, apoptosis regulation, and extracellular matrix remodeling. Its abnormal expression is associated with various disease states, including neurodegenerative diseases, tumor metastasis, and autoimmune disorders.

2. Technical Advantages of Cathepsin F His Tag Protein

Cathepsin F His Tag Protein is a recombinant protein prepared through genetic engineering, offering significant advantages in design and functionality:

1. High-Efficiency Purification: The C- or N-terminal 6×His tag enables efficient binding to nickel-ion affinity chromatography columns, achieving one-step high-purity protein purification with recovery rates exceeding 90%.

2. Excellent Activity Retention: The recombinant expression system produces Cathepsin F protein with intact enzymatic activity, comparable to that of the native protein, typically with Km values in the μM range.

3. Enhanced Stability: The introduction of the His tag not only facilitates purification but also improves protein stability, allowing activity to be maintained for weeks under appropriate conditions.

4. Versatile Applications: Suitable for enzymatic property studies, antigen development for antibodies, or as a standard for activity assays.

3. Main Application Areas

1. Enzymatic Property Studies

- Substrate Specificity Analysis: Analyze the cleavage site preferences of Cathepsin F using fluorescent or protein substrates to determine optimal pH and temperature conditions.

- Inhibitor Screening: Use as a target protein for high-throughput screening of natural or synthetic small-molecule inhibitors, evaluating IC50 values and inhibition kinetics.

- Activation Mechanism Research: Study the autocatalytic removal of the propeptide and activation conditions.

2. Disease Mechanism Research

- Neurodegenerative Disease Models: Investigate the role of Cathepsin F in the degradation of pathological proteins such as α-synuclein and tau in cell or animal models.

- Tumor Invasion Studies: Analyze Cathepsin F's ability to degrade extracellular matrix proteins (e.g., laminin, collagen) and its role in tumor metastasis.

- Immunomodulatory Functions: Study its impact on antigen processing in antigen-presenting cells and its role in autoimmune responses.

3. Drug Development Applications

- Drug Target Validation: Use as a therapeutic target for the design and optimization of novel inhibitors.

- Biomarker Development: Establish disease diagnostic or prognostic evaluation methods based on Cathepsin F activity.

- Antibody Drug Development: Use as an immunogen for therapeutic monoclonal antibody development.

4. Experimental Methods and Optimization Strategies

1. Protein Preparation Process

- Expression System Selection: Mammalian expression systems yield glycosylation modifications closest to the native protein, while E. coli systems are suitable for large-scale production.

- Purification Condition Optimization: Use imidazole gradient elution and optimize pH and salt concentration to improve purity and recovery.

- Activity Refolding: For inclusion body-expressed proteins, gradient dialysis is required for refolding.

2. Activity Assay Methods

- Fluorescent Substrate Assay: Monitor enzymatic activity changes in real-time using fluorescent substrates like Z-Phe-Arg-AMC.

- Gel Zymography: Detect proteolytic activity in polyacrylamide gels containing gelatin or collagen.

- HPLC/MS Analysis: Precisely determine cleavage sites and efficiency for protein substrates.

3. Storage and Stability Studies

- Optimal Storage Conditions: Typically stored long-term at -80°C in buffers containing stabilizers (e.g., glycerol, BSA).

- Activity Preservation Strategies: Avoid repeated freeze-thaw cycles; use small-volume aliquots.

- Quality Control Standards: Standardized testing for purity, concentration, and activity for each batch.

5. Research Progress and Future Directions

1. Structural Biology Research
Determine the three-dimensional structure of Cathepsin F, particularly its complexes with inhibitors or substrates, using X-ray crystallography or cryo-EM to provide a structural basis for drug design.

2. Disease Association Studies
Explore the expression changes and functional abnormalities of Cathepsin F in specific diseases (e.g., Parkinson's disease, rheumatoid arthritis) to identify new therapeutic targets.

3. Diagnostic Application Development
Develop early disease diagnostic methods based on Cathepsin F activity or expression levels, particularly for early biomarkers of neurodegenerative diseases.

6. Which Manufacturers Provide Cathepsin F His Tag Protein?

Nanjing U-Protein independently developed Cathepsin F His Tag Protein, Human (Catalog No.: UA011221), a high-purity, high-activity recombinant protease of human Cathepsin F. Prepared using a mammalian expression system, it carries a C-terminal His tag for easy purification and detection. Cathepsin F is a lysosomal cysteine protease that plays a vital role in antigen presentation, protein degradation, and neurodegenerative diseases. This product is suitable for enzymatic property studies, substrate specificity analysis, inhibitor screening, and disease mechanism research, providing a reliable, high-quality research tool.

Nanjing U-Protein is committed to providing high-quality, high-performance recombinant protease tools for enzymology, immunology, and disease mechanism research. For detailed technical parameters, enzyme activity validation data, or application guidance on Cathepsin F His Tag Protein, Human (Catalog No.: UA011221), please feel free to contact us.